Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots

Moderna took a nearly $500 million hit on write-downs for vaccine inventory that has expired or is expected to expire before is can be used.

from Health and Science https://ift.tt/gHL1KXQ
https://ift.tt/30mJB5f
https://ift.tt/4rvMuEJ